Company Quick10K Filing
Nanthealth
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-21
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-15
8-K 2020-05-07 Earnings, Exhibits
8-K 2020-03-10 Officers, Exhibits
8-K 2020-02-28 Earnings, Exhibits
8-K 2020-02-06 M&A, Exhibits
8-K 2020-01-13 Enter Agreement, Other Events, Exhibits
8-K 2019-11-07 Earnings, Exhibits
8-K 2019-11-06
8-K 2019-08-08 Earnings, Exhibits
8-K 2019-08-07 Officers
8-K 2019-06-24
8-K 2019-06-13 Shareholder Vote, Other Events
8-K 2019-05-09 Earnings, Exhibits
8-K 2019-05-06
8-K 2019-03-28 Officers
8-K 2019-03-28 Earnings, Exhibits
8-K 2019-01-18
8-K 2018-11-15 Earnings, Exhibits
8-K 2018-09-06 Officers, Other Events
8-K 2018-08-19 Officers
8-K 2018-08-09 Earnings, Exhibits
8-K 2018-06-08 Officers, Shareholder Vote, Exhibits
8-K 2018-05-09 Earnings, Exhibits
8-K 2018-03-14 Earnings, Exhibits
8-K 2018-03-05 Officers

Nanthealth Financials

NH Metrics, Comps, Filings

Quarterly | Annual

Business

NantHealth is a next-generation healthcare technology company that is transforming the way critical diseases, such as cancer, are known and treated. Specifically, we employ precision medicine and technology to give physicians, payers, pharma and patients more actionable information.

To accomplish this, we employ a unique systems-based approach to personalized healthcare providing leading solutions across the continuum of care for physicians, payers patients and biopharmaceutical organizations, enabling the use of cutting edge data and technology towards the goals of empowering clinical decision support and improving patient outcomes. NantHealth's comprehensive product portfolio combines the latest technology in molecular analysis (GPS Cancer and Liquid GPS), payer/provider collaboration platforms that exchange information in near-real time (NaviNet and Eviti), and connected care solutions that deliver Medical Device Interoperability (MDI) through vendor neutral medical device connectivity.

As a pioneer in the era of big data and augmented intelligence, we believe we are uniquely positioned to benefit from multiple significant market opportunities as healthcare providers and payers transition from fee-for-service to value-based reimbursement models and accelerate their pursuit of evidence-based clinical practice.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Fang Holdings (SFUN) 120 0% 1,824 1,229 0 0 0 0 346
Park City Group (PCYG) 115 70% 24.5 6% 53 10 20 14 3 4 97
Leaf Group (LEAF) 114 24% -7.4 -26% 82 31 110 26 -22 -14 101
Asure Software (ASUR) 103 30% 21.5 -3% 335 242 162 49 -11 10 210
Veritone (VERI) 89 65% -0.9 -40% 118 68 37 24 -47 -45 39
Innovative Solutions & Support (ISSC) 78 56% 24.3 5% 39 2 18 10 2 2 56
Nanthealth (NH) 76 57% -0.8 -36% 278 325 95 54 -100 -83 66
Computer Task Group (CTG) 69 5% 11.1 -2% 152 86 388 18 -3 5 58
Rumbleon (RMBL) 63 6% -2.1 -26% 115 89 714 42 -30 -24 50
Realnetworks (RNWK) 61 43% -2.8 -12% 177 133 145 63 -21 -15 41
CSP (CSPI) 56 23% -230.0 -1% 59 29 79 18 -0 -0 38
GreenPro Capital (GRNQ) 47 65% -79.3 -9% 9 5 3 2 -1 -1 46
Mind CTI (MNDO) 45 0% 26 5 0 0 0 0 42
Support.com (SPRT) 43 26% 5.4 6% 57 5 50 13 4 4 21
Innodata (INOD) 33 0% 15.3 -3% 52 23 41 0 -2 2 24
Perion Network (PERI) 31 0% 256 108 0 0 0 0 -10
Widepoint (WYY) 26 17% 14.2 0% 56 31 74 13 0 1 19
Streamline Health Solutions (STRM) 25 0% -918.4 -3% 32 17 16 0 -1 -0 29
Net Element (NETE) 22 6% -17.6 -21% 23 17 48 3 -5 -2 30
MTech Acquisition (MTEC) 22 105.0 0% 59 54 0 0 0 0 22

Balance Sheet ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash761601259373624831241814810
Accounts Receivable1314911121115191715151411
Inventory2222111110000
PP&E54445154394024242523211816
Assets640684640565467449431412318286285268278
Accounts Payable7741435522233
Long-Term Debt
Liabilities189273270266258256260264266284302299325
Stockholders' Equity451412370300209193171148513-16-30-47
Income Statement ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue25242326222222222223242622
Cost of Revenue17619171191111111111108
Gross Profit84310101311111111121614
R&D1413131289565555
SG&A252121231821211817171515
Tax0-4000-2-1-1-200-1
Net Income-37-60-41-70-42-22-22-23-97-49-20-15-16
Cash Flow ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-18-26-29-19-8-13-10-3-5-43
Cash Investing0-7-3-1-1-0-5-4-1-1-1
Cash Financing103-2-1-0-3-0-2-0-0-01